CLINICAL_TRIALS
trial_result
· 2021-06-30
Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia [Phase 3]
Summary
Phase 3 trial evaluating safety and efficacy of tocilizumab in patients with severe COVID-19 pneumonia has completed; results were posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: COVID-19 Pneumonia | Phase 3 | Status: COMPLETED | Results posted: 2021-06-30